107 related articles for article (PubMed ID: 1526261)
1. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
3. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment?
Larsen B; Thompson C; Kwan A; Farid NR
Tissue Antigens; 1986 Nov; 28(5):298-300. PubMed ID: 3824363
[TBL] [Abstract][Full Text] [Related]
6. [Tissue polypeptide antigen in thyroid cancer].
Nomizu T; Watanabe I; Endo S
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1289-95. PubMed ID: 6595323
[No Abstract] [Full Text] [Related]
7. [Cellular immunologic parameters in thyroid diseases].
Beyer PA; Wenisch HJ; Schumm-Draeger PM; Hanisch E; Seufert RM; Encke A
Acta Med Austriaca; 1989; 16(1):6-7. PubMed ID: 2785324
[TBL] [Abstract][Full Text] [Related]
8. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
9. Papillary carcinoma of the thyroid. A histochemical, immunohistochemical and ultrastructural study with special reference to the follicular variant.
Eimoto T; Naito H; Hamada S; Masuda M; Harada T; Kikuchi M
Acta Pathol Jpn; 1987 Oct; 37(10):1563-79. PubMed ID: 3434281
[TBL] [Abstract][Full Text] [Related]
10. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
11. Associations between HLA-C alleles and papillary thyroid carcinoma.
Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
[TBL] [Abstract][Full Text] [Related]
12. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
13. [Antigens CA-50 and CA-242 in digestive tract and thyroid neoplasms].
Pomorski L; Pasieka Z; Kołomecki K; Czyz W; Kołodziejczyk M; Wróbel B
Wiad Lek; 1997; 50 Suppl 1 Pt 1():18-20. PubMed ID: 9446350
[TBL] [Abstract][Full Text] [Related]
14. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic reversion in tumors of the thyroid].
Bochanovskiĭ VA; Anokhin BM
Probl Endokrinol (Mosk); 1986; 32(3):11-3. PubMed ID: 2426693
[TBL] [Abstract][Full Text] [Related]
16. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
Tuccari G; Barresi G
Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
[TBL] [Abstract][Full Text] [Related]
18. [Cellular immunologic studies in pediatric and juvenile thyroid cancer].
Boros P; Csáky G; Balázs G; Szegedi G
Zentralbl Chir; 1986; 111(19):1179-82. PubMed ID: 3492839
[TBL] [Abstract][Full Text] [Related]
19. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases.
Logmans SC; Jöbsis AC
Cancer; 1984 Jul; 54(2):274-9. PubMed ID: 6202390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
